Stressor-responsive central nesfatin-1 activates corticotropinreleasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis

Aging

Volumn 2, Issue 11, 2010, Pages 775-784

  Yoshida, Natsu ^a   Maejima, Yuko ^a   Sedbazar, Udval ^a   Ando, Akihiko ^a   Kurita, Hideharu ^a   Damdindorj, Boldbaatar ^a   Takano, Eisuke ^a   Gantulga, Darambazar ^a   Iwasaki, Yusaku ^a   Kurashina, Tomoyuki ^a   Onaka, Tatsushi ^a   Dezaki, Katsuya ^a   Nakata, Masanori ^a   Mori, Masatomo ^b   Yada, Toshihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C Fos; Calcium; Crh; HPA axis; Nesfatin 1; Paraventricular nucleus; Stress

Indexed keywords

CALCIUM; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; NERVE PROTEIN; NESFATIN 1 PROTEIN, RAT; NESFATIN-1 PROTEIN, RAT; NORADRENALIN; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BLOOD; CYTOLOGY; DRUG EFFECT; EXERCISE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOCUS CERULEUS; MALE; MENTAL STRESS; METABOLISM; NERVE CELL; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RAPHE NUCLEUS; RAT; SOLITARY TRACT NUCLEUS; SUPRAOPTIC NUCLEUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LOCUS COERULEUS; MALE; NERVE TISSUE PROTEINS; NEURONS; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RAPHE NUCLEI; RATS; RESTRAINT, PHYSICAL; SEROTONIN; SOLITARY NUCLEUS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SUPRAOPTIC NUCLEUS; TYROSINE 3-MONOOXYGENASE;

EID: 79952638327     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100207     Document Type: Article

References (35)

1. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006; 443:709-712.
2. Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, Yoshida N, Dezaki K, Onaka T, Mori M, and Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology. 2008; 149:1295-1301.
3. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, amd Dun NJ. Nesfatin-1: distribution and interaction with a G proteincoupled receptor in the rat brain. Endocrinology. 2007; 148:5088-5094.
4. Foo KS, Brismar H, and Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008; 156:563-579.
5. Yosten GL, and Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol. 2010; 298:R1642-R1647.
6. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metabolism 2009; 10:355-365.
7. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Lambrecht NW, and Taché Y. Central nesfatin-1 reduces darkphase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology. 2009; 150:4911-4919.
8. Nonogaki K, Ohba Y, Sumii M, and Oka Y. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice. Biochem Biophys Res Commun. 2008; 372:186-1890.
9. Merali Z, Cayer C, Kent P, and Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl). 2008; 201:115-123.
10. Liu J, Garza JC, Truong HV, Henschel J, Zhang W, and Lu XY. The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxietylike behavior. Endocrinology. 2007; 148:5531-5540.
11. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, and Lambrecht NW. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology. 2009; 150:232-238.
12. Stengel A, Goebel M, Wang L, and Taché Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides. 2010; 31:357-369.
13. Gonzalez R, Tiwari A, and Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun. 2009; 381:643-648.
14. Foo KS, Brauner H, Ostenson CG, and Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol. 2010; 204:255-263.
15. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, and Randeva HS. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology. 2010; 151:3169-3180.
16. Muroya S, Yada T, Shioda S, and Takigawa M. Glucosesensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett. 1999; 264:113-116.
17. Goebel M, Stengel A, Wang L, and Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res. 2009; 1300:114-124.
18. Merali Z, Cayer C, Kent P, and Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl). 2008; 201:115-123.
19. Price CJ, Hoyda TD, Samson WK, and Ferguson AV. Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J Neuroendocrinol. 2008; 20:245-250.
20. Könczöl K, Bodnár I, Zelena D, Pintér O, Papp RS, Palkovits M, Nagy GM, and Tóth ZE. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int. 2010; 57:189-197.
21. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, Hinuma S, Onda H, Nishimura O, Inoue K, and Fujino M. Stimulation of corticotropin-releasing hormonemediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett. 2000; 285:234-238.
22. Itoi K, Helmreich DL, Lopez-Figueroa MO, and Watson SJ. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci. 1999; 19:5464-5472.
23. Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, Ghatei MA, and Bloom SR. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology. 2006; 147:3510-3518.
24. Noguchi T, Makiko S, Maruyama H, and Hashimoto K. Regulation of proopiomelanocortin gene transcription during single and repeated immobilization stress. Neuroendocrinology. 2006; 84:21-30.
25. Vrang N, Larden PJ, Kristensen P, and Tang-Christensen M. Central administration of cocaine-anphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology. 2000; 141:794-801.
26. Cunningham ET Jr, and Sawchemko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol. 1988; 274:60-76.
27. Sawchenko PE, Swanson LW, Steinbusch HW, and Verhofstad AA. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 1983; 277:355-360.
28. Dong YX, Han ZA, Xiong KH, and Rao ZR. Fos expression in serotonergic midbrain neurons projecting to the paraventricular nucleus of hypothalamus after noxious stimulation of the stomach: a triple labeling study in the rat. Neurosci Res. 1997; 27:155-160.
29. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, and Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology. 1994; 135:2177-2182.
30. Liposits Z, Phelix C, and Paull WK. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry. 1987; 86:541-549.
31. Jørgensen H, Knigge U, Kjaer A, Møller M, and Warberg J. Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. J Neuroendocrinol. 2002; 14:788-795.
32. Leibowitz SF, Diaz S, and Tempel D. Norepinephrine in the paraventricular nucleus stimulates corticosterone release. Brain Res. 1989; 496:219-227.
33. Gaillet S, Lachuer J, Malaval F, Assenmacher I, and Szafarczyk A. The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors. Exp Brain Res.
34. Fuller RW, and Snoddy HD. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Neuroendocrinology. 1980; 31:96-100.
35. Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, Yeo GS, O'Rahilly S, Colmers WF, Elmquist JK, and Tecott LH. Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci. 2007; 27:6956-6964.